CRVS News and Press, Corvus Pharmaceuticals Inc. From 09/18/21

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks touched their lowest levels in four weeks Friday as inflation fears took hold and a range of Chinese economic indicators pointed to a ...

3 Penny Stocks to Add to Your September Watchlist Right Now With the market hitting a small slump today, there are still plenty of penny stocks that are showing potential. To understand why the broader stock market is down, we have to take a look at the industry wholly. It seems as thou...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Corvus Pharmaceuticals (NASDAQ: CRVS ) stock is rising higher on Friday despite a lack of news from the company. Source: Vitalii Vodolazskyi / Shutterstock.com Let’s take a look at what traders need to ...

Gainers: Corvus Pharmaceuticals (NASDAQ:CRVS) +73%, Innate Pharma IPHA +51%, SmileDirectClub (NASDAQ:SDC) +12%, Biomerica (NASDAQ:BMRA) +9%, I-Mab (NASDAQ:IMAB) +6%. Losers: Protagonist Therapeutics PTGX -62%, TCR2 Therapeutics TCRR -31%,...

Corvus Pharmaceuticals (NASDAQ:CRVS) +56%. Innate Pharma (NASDAQ:IPHA) +32% Monalizumab data from COAST trial presented at ESMO Congress 2021 Surface Oncology (NASDAQ:SURF) +14%. BeiGene (NASDAQ:BGNE) +13% on positive DKN-01 + tislelizumab data in gastroesophageal cancer AbCell...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! There’s only one day of trading left so let’s start it off right with a look at the biggest pre-market stock movers for Friday. Source: ventdusud / Shutterstock.com We’re s...

BURLINGAME, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that an IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. (Angel Pharma), for the initiation of a Phase ...

Rapid adoption of advanced technologies, coupled with continued investments in developing breakthrough drugs, makes the prospects bright for the biotech industry. Moreover, the success of biotech firms in efficiently responding to the devastation caused by the COVID-19 pandemic has evoked a p...

BURLINGAME, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a business update and reported financial results for the second quarter ended June 30, 2021. “We continue to advance mup...

At the mid-year mark, our contributors give updates on their picks. We highlight two recent top performers. And stay tuned for next week, where some contributors introduce new ideas with the Double Down or Diversify series. For further details see: SA Marketplace 2021 To...